Home » Newsletters » BioWorld Science

BioWorld Science

June 30, 2008

View Archived Issues

XOMA-052 shows antiarthritic effects in murine CIA model

New class of amyloid-inhibiting agents described

Combination of IMC-11F8 and mFOLFOX-6 appears well tolerated in colorectal cancer

New data on axitinib in metastatic cancers presented

Bristol-Myers Squibb's acquisition of Kosan Biosciences complete

Positive E.U. opinion issued to extend use of bosentan in pulmonary hypertension

CHMP issues positive opinion for Cymbalta in generalized anxiety disorder

CHMP issues positive opinion for UCB's Vimpat in epilepsy

CHMP recommends approval of Abstral for breakthrough cancer pain

Lux Biosciences completes enrollment in LUMINATE clinical trial program for Luveniq

Merck & Co. initiates phase IIb clinical trial of SurModics' I-vation intravitreal implant

FDA issues complete response to Merck & Co.'s sBLA for Gardasil in women ages 27 to 45

Results from preclinical studies of oral CP-4126 support advancement into clinical studies

Sun Pharmaceutical exercises options to acquire shares of controlling shareholders of Taro

Medicago reports additional results from preclinical study of H5N1 VLP vaccine

Hisamitsu files for approval in Japan of HFT-290 in cancer pain

Recent patents disclose novel antiinfective agents

ACR-325 advances into phase II PoC studies in PD, bipolar disorder

PN-277 shows benefit in experimental Parkinson's disease

SciClone and Sigma-Tau present update on phase III trial of Zadaxin in HCV

FDA accepts for priority review Eisai's sBLA for Ontak in CTCL

ImClone initiates enrollment in phase I clinical trial of IMC-A12 plus temsirolimus

New agents for endocrine-associated disorders disclosed in recent patents

Compugen discovers biomarkers for early detection of kidney toxicity

CHMP issues positive opinion for Tibotec's etravirine in HIV infection

Novel agents for psychiatric disorders reported in recent patent literature

German approval for Oralair Grasses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...